Control for SARS-CoV-2 Antibody Assay

$250.00

In Stock & Ready to Ship

Mixture of recombinant humanized IgG and IgM monoclonal antibodies directed against the NP protein of SARS-CoV-2 virus. This serves as an excellent and harmless positive control for Anti-SARS-CoV-2 immunoassays.

Share:
Compare

For Research Use Only. Not for use in Diagnostic Procedures.

You may also like…

SARS-CoV-2 Antibody Detection Assay

$150.00

This is an Antibody Serologic Assay (SCSA) for SARS-CoV-2. 

 

This test has not been reviewed by the FDA.

 

The SARS-CoV-2 Antibody rapid test is a lateral flow chromatographic immunoassay for the qualitative detection of IgM/IgG anti-SARS CoV-2 antibody which may be found in samples such as serum, plasma, whole blood or cell culture media. This product is suitable for screening for the presence of SARS-CoV-2 reactive antibody in a Research Use Only Fashion.

Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.

Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.

Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.